BibTex RIS Kaynak Göster

Treatment Of Postoperative Atelectasis With Dornase Alpha (Pulmozyme®) After Congenital Heart Surgery

Yıl 2015, Cilt: 2 Sayı: 4, 275 - 77, 27.04.2015

Mustafa Zor Abdullah Ozer , Huseyin Demirtas Yigit Kilic Baris Mardin

Öz

One year old patient followed with tetralogy of fallot (TOF) was admitted to our service for surgical repair. Ventricular septal defect (VSD) was repaired with a Dacron patch. The infundibular  muscle was resected to allow for unobstructed flow of blood to the pulmonary valve and the area above the pulmonary valve was opened with a polytetrafluoroethylene (PTFE) patch. The patient was intubated three times bacause of the  atelectasis ocurred in the lungs after the surgery. Atelectasis was treated with nebulised dornase alpha. It avoided the recurrence of atelectasis and the patient was discharged.

Anahtar Kelimeler

Atelectasis; Dornase Alpha (Pulmozyme®); Congenital Heart Surgery

Kaynakça

  • Pinto Jr VC, Daher CV, Sallum FS, Janete MB, Croti UA. Situação das cirurgias cardíacas congênitas no Brasil. Rev Bras Cir Cardiovascular. 2004; 19(2): 3-4
  • Felcar JM, Guitti JCS, Marson AC, Cardoso JR. Fisioterapiapré-operatória na prevenção das complicações pulmonares emcirurgia cardíaca pediátrica. Rev Bras Cir Cardiovasc. 2008; 23(3):383-8.
  • Andrejaitiene J, Sirvinskas E, Bolys R. The influence of cardiopulmonary bypass on respiratory dysfunction in early postoperative period. Medicina (Kaunas). 2004; 40(Suppl1):7-12.
  • Kavanagh BP. Perioperative atelectasis. Minerva Anestesiol. 2008; 74(6):285-7.
  • Undern-Sternberg BS, Petak F, Saudan S, Pellegrini M, Erb TO, Habre W. Effect of cardiopulmonary bypass and aortic clamping on functional residual capacity and ventilation distribution in children. J Thorac Cardiovasc Surg. 2007; 134(5): 1193-8.
  • Nina RVAH, Gama MEA, Santos AM, Nina VJS, Figueiredo NETO JA, Mendes VGG, et al. O escore de risco ajustado para cirurgia em cardiopatias congênitas (RACHS-1) pode ser aplicado em nosso meio? Rev Bras Cir Cardiovasc. 2007; 22(4): 425-31.
  • Healy, Fiona; D. Hanna, Brian; Zinman, Raezelle Current Respiratory Medicine Reviews, Volume 7, Number 2, April 2011 , pp. 78-86(9 Bentham Science Publishers
  • Lee A. Fleisher. Anesthesia and uncommon disease. Elsevier Health Sciences, 2012; Sixth Ed. pp (6-7)
  • Oh AY, Kim YH, Kim BK, Kim HS, Kim CS Unexpected tracheomalacia in Marfan syndrome during general anesthesia for correction of scoliosis. Anesth Analg 2002; 95: 331-2.
  • Kanter RK, Pollack MM, Wright WW, et al. Treatment of severe tracheobronchomalacia with continuous positive airway pressure (CPAP). Anesthesiology 1982; 57: 54–6.
  • Shah PL, Scott SF, Knight RA, et al. In vivo effect of rhDNase 1 on sputum in patients with cystic fibrosis. Thorax 1996;51(2):119-25.
  • Hassan NO, Chess PR. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates. Pediatrics 2001;108:468.
  • Toulemiat B, Conoscenti G, Fine J. Recombinant human Dnase in management of lobar atelectasis due to retained secretions. Thorax 1995;50:1319-21.

Treatment of postoperative atelectasis with dornase alpha (Pulmozyme®) after congenital heart surgery

Yıl 2015, Cilt: 2 Sayı: 4, 275 - 77, 27.04.2015

Mustafa Zor Abdullah Ozer , Huseyin Demirtas Yigit Kilic Baris Mardin

Öz

Kaynakça

  • Pinto Jr VC, Daher CV, Sallum FS, Janete MB, Croti UA. Situação das cirurgias cardíacas congênitas no Brasil. Rev Bras Cir Cardiovascular. 2004; 19(2): 3-4
  • Felcar JM, Guitti JCS, Marson AC, Cardoso JR. Fisioterapiapré-operatória na prevenção das complicações pulmonares emcirurgia cardíaca pediátrica. Rev Bras Cir Cardiovasc. 2008; 23(3):383-8.
  • Andrejaitiene J, Sirvinskas E, Bolys R. The influence of cardiopulmonary bypass on respiratory dysfunction in early postoperative period. Medicina (Kaunas). 2004; 40(Suppl1):7-12.
  • Kavanagh BP. Perioperative atelectasis. Minerva Anestesiol. 2008; 74(6):285-7.
  • Undern-Sternberg BS, Petak F, Saudan S, Pellegrini M, Erb TO, Habre W. Effect of cardiopulmonary bypass and aortic clamping on functional residual capacity and ventilation distribution in children. J Thorac Cardiovasc Surg. 2007; 134(5): 1193-8.
  • Nina RVAH, Gama MEA, Santos AM, Nina VJS, Figueiredo NETO JA, Mendes VGG, et al. O escore de risco ajustado para cirurgia em cardiopatias congênitas (RACHS-1) pode ser aplicado em nosso meio? Rev Bras Cir Cardiovasc. 2007; 22(4): 425-31.
  • Healy, Fiona; D. Hanna, Brian; Zinman, Raezelle Current Respiratory Medicine Reviews, Volume 7, Number 2, April 2011 , pp. 78-86(9 Bentham Science Publishers
  • Lee A. Fleisher. Anesthesia and uncommon disease. Elsevier Health Sciences, 2012; Sixth Ed. pp (6-7)
  • Oh AY, Kim YH, Kim BK, Kim HS, Kim CS Unexpected tracheomalacia in Marfan syndrome during general anesthesia for correction of scoliosis. Anesth Analg 2002; 95: 331-2.
  • Kanter RK, Pollack MM, Wright WW, et al. Treatment of severe tracheobronchomalacia with continuous positive airway pressure (CPAP). Anesthesiology 1982; 57: 54–6.
  • Shah PL, Scott SF, Knight RA, et al. In vivo effect of rhDNase 1 on sputum in patients with cystic fibrosis. Thorax 1996;51(2):119-25.
  • Hassan NO, Chess PR. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates. Pediatrics 2001;108:468.
  • Toulemiat B, Conoscenti G, Fine J. Recombinant human Dnase in management of lobar atelectasis due to retained secretions. Thorax 1995;50:1319-21.
Toplam 13 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Vaka Sunumu
Yazarlar

Mustafa Zor Bu kişi benim

Abdullah Ozer

Huseyin Demirtas Bu kişi benim

Yigit Kilic Bu kişi benim

Baris Mardin Bu kişi benim

Yayımlanma Tarihi 27 Nisan 2015
Yayımlandığı Sayı Yıl 2015 Cilt: 2 Sayı: 4

Kaynak Göster

APA Zor, M., Ozer, A., Demirtas, H., Kilic, Y., vd. (2015). Treatment Of Postoperative Atelectasis With Dornase Alpha (Pulmozyme®) After Congenital Heart Surgery. Medical Science and Discovery, 2(4), 275-77. https://doi.org/10.17546/msd.38808
AMA Zor M, Ozer A, Demirtas H, Kilic Y, Mardin B. Treatment Of Postoperative Atelectasis With Dornase Alpha (Pulmozyme®) After Congenital Heart Surgery. Med Sci Discov. Haziran 2015;2(4):275-77. doi:10.17546/msd.38808
Chicago Zor, Mustafa, Abdullah Ozer, Huseyin Demirtas, Yigit Kilic, ve Baris Mardin. “Treatment Of Postoperative Atelectasis With Dornase Alpha (Pulmozyme®) After Congenital Heart Surgery”. Medical Science and Discovery 2, sy. 4 (Haziran 2015): 275-77. https://doi.org/10.17546/msd.38808.
EndNote Zor M, Ozer A, Demirtas H, Kilic Y, Mardin B (01 Haziran 2015) Treatment Of Postoperative Atelectasis With Dornase Alpha (Pulmozyme®) After Congenital Heart Surgery. Medical Science and Discovery 2 4 275–77.
IEEE M. Zor, A. Ozer, H. Demirtas, Y. Kilic, ve B. Mardin, “Treatment Of Postoperative Atelectasis With Dornase Alpha (Pulmozyme®) After Congenital Heart Surgery”, Med Sci Discov, c. 2, sy. 4, ss. 275–77, 2015, doi: 10.17546/msd.38808.
ISNAD Zor, Mustafa vd. “Treatment Of Postoperative Atelectasis With Dornase Alpha (Pulmozyme®) After Congenital Heart Surgery”. Medical Science and Discovery 2/4 (Haziran 2015), 275-77. https://doi.org/10.17546/msd.38808.
JAMA Zor M, Ozer A, Demirtas H, Kilic Y, Mardin B. Treatment Of Postoperative Atelectasis With Dornase Alpha (Pulmozyme®) After Congenital Heart Surgery. Med Sci Discov. 2015;2:275–77.
MLA Zor, Mustafa vd. “Treatment Of Postoperative Atelectasis With Dornase Alpha (Pulmozyme®) After Congenital Heart Surgery”. Medical Science and Discovery, c. 2, sy. 4, 2015, ss. 275-77, doi:10.17546/msd.38808.
Vancouver Zor M, Ozer A, Demirtas H, Kilic Y, Mardin B. Treatment Of Postoperative Atelectasis With Dornase Alpha (Pulmozyme®) After Congenital Heart Surgery. Med Sci Discov. 2015;2(4):275-77.
 Kapak Resmi İndir